Use of psychotropic medication linked to dementia following SARS-CoV-2 infection

Older patients taking psychotropic medication were about three times more likely to develop dementia following a SARS-CoV-2 infection, researchers reported in Frontiers in Medicine.
Liron Sinvani, MD, assistant professor at the Institute of Health System Science at the Feinstein Institutes, and colleagues assessed electronic health records of 1,755 adults aged 65 years and older to determine the 1-year incidence rate of post-COVID-19 dementia, as well as the association between that and psychotropic medication use.
“COVID-19 can have a profound, lingering effect on a person's physical and

Older patients taking psychotropic medication were about three times more likely to develop dementia following a SARS-CoV-2 infection, researchers reported in Frontiers in Medicine.
Liron Sinvani, MD, assistant professor at the Institute of Health System Science at the Feinstein Institutes, and colleagues assessed electronic health records of 1,755 adults aged 65 years and older to determine the 1-year incidence rate of post-COVID-19 dementia, as well as the association between that and psychotropic medication use.
“COVID-19 can have a profound, lingering effect on a person’s physical and